 Jay Vivian
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Animals | 35 | 2024 | 729 | 1.670 |
Why?
| | Mice | 25 | 2023 | 348 | 1.440 |
Why?
| | Embryonic Stem Cells | 5 | 2013 | 11 | 1.210 |
Why?
| | Cell Differentiation | 8 | 2021 | 59 | 1.010 |
Why?
| | Embryonic Development | 3 | 2020 | 13 | 0.950 |
Why?
| | Signal Transduction | 6 | 2018 | 132 | 0.940 |
Why?
| | Animals, Laboratory | 1 | 2023 | 2 | 0.910 |
Why?
| | Trophoblasts | 4 | 2024 | 16 | 0.910 |
Why?
| | Transforming Growth Factor beta | 3 | 2013 | 13 | 0.900 |
Why?
| | Nodal Protein | 3 | 2013 | 5 | 0.890 |
Why?
| | Mitochondria | 1 | 2023 | 11 | 0.870 |
Why?
| | Blastocyst | 3 | 2020 | 4 | 0.790 |
Why?
| | Pluripotent Stem Cells | 4 | 2014 | 5 | 0.740 |
Why?
| | Neoplasms | 1 | 2023 | 128 | 0.730 |
Why?
| | Sendai virus | 1 | 2020 | 1 | 0.710 |
Why?
| | Primary Cell Culture | 1 | 2020 | 5 | 0.710 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 8 | 0.700 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 4 | 0.700 |
Why?
| | CRISPR-Cas Systems | 1 | 2020 | 13 | 0.700 |
Why?
| | Myogenin | 5 | 2000 | 5 | 0.590 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2013 | 8 | 0.530 |
Why?
| | Jaundice | 3 | 2022 | 4 | 0.510 |
Why?
| | Neural Stem Cells | 3 | 2022 | 7 | 0.510 |
Why?
| | Placentation | 3 | 2024 | 15 | 0.450 |
Why?
| | DNA-Binding Proteins | 3 | 2015 | 39 | 0.440 |
Why?
| | Placenta | 3 | 2024 | 21 | 0.420 |
Why?
| | Mutation | 7 | 2016 | 212 | 0.420 |
Why?
| | Yolk Sac | 2 | 2011 | 2 | 0.410 |
Why?
| | Cell Lineage | 4 | 2024 | 22 | 0.390 |
Why?
| | Receptors, Notch | 1 | 2011 | 4 | 0.380 |
Why?
| | Blood Vessels | 1 | 2011 | 5 | 0.380 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 2 | 2022 | 2 | 0.370 |
Why?
| | Kidney Tubules, Collecting | 2 | 2022 | 3 | 0.370 |
Why?
| | Pregnancy | 7 | 2024 | 216 | 0.360 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2010 | 1 | 0.360 |
Why?
| | Rats | 9 | 2024 | 106 | 0.350 |
Why?
| | Mice, Transgenic | 8 | 2023 | 35 | 0.330 |
Why?
| | Stem Cells | 5 | 2021 | 29 | 0.320 |
Why?
| | Female | 15 | 2024 | 3525 | 0.320 |
Why?
| | Humans | 13 | 2024 | 6896 | 0.300 |
Why?
| | Prolactin | 2 | 2017 | 3 | 0.280 |
Why?
| | Cell Proliferation | 3 | 2018 | 58 | 0.280 |
Why?
| | Alleles | 3 | 2002 | 214 | 0.280 |
Why?
| | Transcription Factors | 3 | 2015 | 52 | 0.270 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 14 | 0.270 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2015 | 51 | 0.270 |
Why?
| | Infertility, Female | 2 | 2017 | 4 | 0.270 |
Why?
| | Homeodomain Proteins | 3 | 2014 | 20 | 0.250 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 101 | 0.250 |
Why?
| | Muscle, Skeletal | 3 | 1999 | 12 | 0.250 |
Why?
| | Cell Nucleus | 2 | 2023 | 7 | 0.240 |
Why?
| | Mice, Knockout | 6 | 2020 | 59 | 0.240 |
Why?
| | Trans-Activators | 2 | 2010 | 14 | 0.240 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2022 | 8 | 0.230 |
Why?
| | Mice, Inbred C57BL | 6 | 2020 | 92 | 0.230 |
Why?
| | Rosa | 1 | 2023 | 1 | 0.230 |
Why?
| | DNA, Mitochondrial | 1 | 2023 | 5 | 0.220 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 9 | 0.220 |
Why?
| | Male | 9 | 2023 | 3337 | 0.210 |
Why?
| | Autocrine Communication | 2 | 2014 | 2 | 0.210 |
Why?
| | Sternum | 2 | 2000 | 5 | 0.210 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2022 | 5 | 0.210 |
Why?
| | Cysts | 1 | 2022 | 4 | 0.210 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 90 | 0.210 |
Why?
| | Zygote | 2 | 2020 | 2 | 0.210 |
Why?
| | Erythropoietin | 1 | 2022 | 19 | 0.210 |
Why?
| | Calcium | 1 | 2022 | 41 | 0.200 |
Why?
| | Kernicterus | 1 | 2022 | 7 | 0.200 |
Why?
| | Benzamides | 2 | 2013 | 2 | 0.200 |
Why?
| | Smad7 Protein | 2 | 2013 | 3 | 0.200 |
Why?
| | Genetic Testing | 1 | 2002 | 87 | 0.200 |
Why?
| | Dystonia | 1 | 2022 | 8 | 0.200 |
Why?
| | Phosphorylation | 2 | 2013 | 22 | 0.200 |
Why?
| | Fibroblasts | 2 | 2020 | 26 | 0.190 |
Why?
| | Intercostal Muscles | 1 | 2000 | 1 | 0.180 |
Why?
| | Myogenic Regulatory Factors | 1 | 2000 | 1 | 0.180 |
Why?
| | Thorax | 1 | 2000 | 4 | 0.180 |
Why?
| | Somites | 1 | 2000 | 4 | 0.180 |
Why?
| | Phenotype | 4 | 2018 | 257 | 0.180 |
Why?
| | Cilia | 1 | 2020 | 1 | 0.180 |
Why?
| | Flagella | 1 | 2020 | 1 | 0.180 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 7 | 0.180 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 1 | 0.180 |
Why?
| | Cells, Cultured | 4 | 2018 | 84 | 0.180 |
Why?
| | Membrane Proteins | 1 | 2020 | 54 | 0.170 |
Why?
| | Gonadotropins | 2 | 2017 | 5 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 41 | 0.170 |
Why?
| | Gene Targeting | 1 | 1999 | 5 | 0.170 |
Why?
| | Lac Operon | 1 | 1999 | 2 | 0.170 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 1999 | 2 | 0.170 |
Why?
| | Cell Adhesion Molecules | 2 | 2018 | 4 | 0.170 |
Why?
| | Muscle Development | 1 | 1999 | 1 | 0.170 |
Why?
| | RNA, Messenger | 4 | 2014 | 115 | 0.170 |
Why?
| | Epithelial Cells | 1 | 2018 | 7 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 71 | 0.160 |
Why?
| | Median Eminence | 1 | 2018 | 1 | 0.160 |
Why?
| | Muscle Proteins | 3 | 2012 | 6 | 0.160 |
Why?
| | Estrogen Receptor beta | 1 | 2017 | 1 | 0.150 |
Why?
| | Glycoproteins | 1 | 2017 | 9 | 0.150 |
Why?
| | Embryo, Mammalian | 2 | 2010 | 11 | 0.150 |
Why?
| | Fertility | 1 | 2017 | 18 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 4 | 2021 | 50 | 0.150 |
Why?
| | Erythropoiesis | 2 | 2022 | 3 | 0.140 |
Why?
| | Smad2 Protein | 2 | 2010 | 3 | 0.140 |
Why?
| | Testis | 1 | 2017 | 26 | 0.140 |
Why?
| | Progesterone | 1 | 2016 | 2 | 0.140 |
Why?
| | Adaptation, Physiological | 1 | 2016 | 4 | 0.140 |
Why?
| | Reproduction | 1 | 2016 | 7 | 0.140 |
Why?
| | Brain | 1 | 2017 | 80 | 0.140 |
Why?
| | Stress, Physiological | 1 | 2016 | 7 | 0.130 |
Why?
| | Base Sequence | 3 | 2015 | 81 | 0.130 |
Why?
| | Genotype | 2 | 2011 | 410 | 0.130 |
Why?
| | Protein Isoforms | 2 | 2017 | 16 | 0.130 |
Why?
| | Transcription, Genetic | 2 | 2013 | 44 | 0.130 |
Why?
| | Crosses, Genetic | 3 | 2014 | 6 | 0.130 |
Why?
| | Microarray Analysis | 2 | 2015 | 6 | 0.130 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 8 | 0.130 |
Why?
| | Rats, Gunn | 3 | 2022 | 4 | 0.130 |
Why?
| | Cell Line | 2 | 2013 | 81 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 2014 | 30 | 0.120 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 8 | 0.120 |
Why?
| | Models, Biological | 1 | 2014 | 65 | 0.120 |
Why?
| | RNA Interference | 2 | 2012 | 16 | 0.120 |
Why?
| | Infertility, Male | 1 | 2014 | 52 | 0.110 |
Why?
| | Diphenylamine | 1 | 2013 | 1 | 0.110 |
Why?
| | Fibroblast Growth Factor 4 | 1 | 2013 | 1 | 0.110 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2013 | 2 | 0.110 |
Why?
| | Mutagenesis | 2 | 2003 | 5 | 0.110 |
Why?
| | Endothelium | 1 | 2011 | 1 | 0.100 |
Why?
| | Extraembryonic Membranes | 1 | 2011 | 1 | 0.100 |
Why?
| | Gene Expression | 2 | 2010 | 67 | 0.100 |
Why?
| | Fetal Development | 1 | 2011 | 4 | 0.100 |
Why?
| | Gene Silencing | 1 | 2011 | 13 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 8 | 0.100 |
Why?
| | Receptors, Cell Surface | 2 | 2022 | 7 | 0.090 |
Why?
| | Fibrosis | 2 | 2022 | 4 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 84 | 0.090 |
Why?
| | Methyltransferases | 1 | 2010 | 9 | 0.090 |
Why?
| | Dioxoles | 1 | 2010 | 1 | 0.090 |
Why?
| | Smad1 Protein | 1 | 2010 | 1 | 0.090 |
Why?
| | Smad5 Protein | 1 | 2010 | 1 | 0.090 |
Why?
| | Left-Right Determination Factors | 1 | 2010 | 1 | 0.090 |
Why?
| | Parvalbumins | 2 | 2022 | 2 | 0.090 |
Why?
| | Immunoblotting | 1 | 2010 | 11 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 126 | 0.090 |
Why?
| | In Situ Hybridization | 3 | 2015 | 11 | 0.090 |
Why?
| | Time Factors | 3 | 2018 | 250 | 0.090 |
Why?
| | Immunohistochemistry | 3 | 2015 | 48 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 1 | 0.080 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 1 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2008 | 7 | 0.080 |
Why?
| | Chromatin | 1 | 2008 | 22 | 0.080 |
Why?
| | Blotting, Western | 3 | 2015 | 17 | 0.080 |
Why?
| | Cell Survival | 2 | 2018 | 20 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2008 | 14 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 2007 | 2 | 0.070 |
Why?
| | Ribosomal Proteins | 1 | 2007 | 4 | 0.070 |
Why?
| | Growth | 1 | 2007 | 11 | 0.070 |
Why?
| | Ethylnitrosourea | 2 | 2003 | 2 | 0.070 |
Why?
| | Pilot Projects | 2 | 2023 | 120 | 0.070 |
Why?
| | Rats, Transgenic | 2 | 2017 | 3 | 0.070 |
Why?
| | Chimera | 2 | 2002 | 4 | 0.060 |
Why?
| | Exons | 2 | 2016 | 34 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2017 | 32 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2015 | 26 | 0.060 |
Why?
| | Models, Animal | 1 | 2024 | 10 | 0.060 |
Why?
| | Uterus | 1 | 2024 | 10 | 0.060 |
Why?
| | Plant Breeding | 1 | 2023 | 1 | 0.060 |
Why?
| | Aromatase | 1 | 2023 | 4 | 0.060 |
Why?
| | Mosaicism | 1 | 2023 | 9 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2003 | 6 | 0.050 |
Why?
| | Genes, Lethal | 1 | 2002 | 1 | 0.050 |
Why?
| | Fetal Heart | 1 | 2002 | 2 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 3 | 0.050 |
Why?
| | Desmin | 2 | 2000 | 2 | 0.050 |
Why?
| | Codon | 1 | 2002 | 3 | 0.050 |
Why?
| | Smad4 Protein | 1 | 2002 | 3 | 0.050 |
Why?
| | Genes, Dominant | 1 | 2002 | 5 | 0.050 |
Why?
| | Point Mutation | 1 | 2002 | 7 | 0.050 |
Why?
| | Genes | 1 | 2002 | 10 | 0.050 |
Why?
| | Pericardium | 1 | 2002 | 5 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 12 | 0.050 |
Why?
| | RNA Splicing | 1 | 2002 | 14 | 0.050 |
Why?
| | Capsaicin | 1 | 2002 | 1 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2002 | 12 | 0.050 |
Why?
| | Hematuria | 1 | 2002 | 6 | 0.050 |
Why?
| | Congenital Abnormalities | 1 | 2002 | 17 | 0.050 |
Why?
| | Arginine Vasopressin | 1 | 2022 | 1 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2022 | 2 | 0.050 |
Why?
| | Proto-Oncogenes | 1 | 2022 | 2 | 0.050 |
Why?
| | Cyclic AMP | 1 | 2022 | 4 | 0.050 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2022 | 3 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 4 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2022 | 1 | 0.050 |
Why?
| | TRPC Cation Channels | 1 | 2022 | 1 | 0.050 |
Why?
| | Erythroid Precursor Cells | 1 | 2022 | 2 | 0.050 |
Why?
| | Epoetin Alfa | 1 | 2022 | 3 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2022 | 7 | 0.050 |
Why?
| | Pain | 1 | 2002 | 57 | 0.050 |
Why?
| | Enkephalins | 1 | 2022 | 1 | 0.050 |
Why?
| | Protein Precursors | 1 | 2022 | 1 | 0.050 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2022 | 3 | 0.050 |
Why?
| | Ribs | 1 | 2000 | 6 | 0.050 |
Why?
| | Protein Transport | 1 | 2020 | 5 | 0.040 |
Why?
| | Arabinofuranosyluracil | 1 | 1999 | 1 | 0.040 |
Why?
| | X Chromosome | 1 | 1999 | 1 | 0.040 |
Why?
| | Histones | 2 | 2010 | 16 | 0.040 |
Why?
| | Histocytochemistry | 1 | 1999 | 4 | 0.040 |
Why?
| | Thymidine Kinase | 1 | 1999 | 2 | 0.040 |
Why?
| | Herpesvirus 1, Human | 1 | 1999 | 4 | 0.040 |
Why?
| | Helix-Loop-Helix Motifs | 1 | 1999 | 2 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 1999 | 6 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 1999 | 49 | 0.040 |
Why?
| | Gene Dosage | 1 | 1999 | 13 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2018 | 2 | 0.040 |
Why?
| | Adult | 2 | 2018 | 1181 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 71 | 0.040 |
Why?
| | Up-Regulation | 1 | 2018 | 25 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2018 | 1 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2018 | 71 | 0.040 |
Why?
| | Disease Progression | 1 | 2018 | 111 | 0.040 |
Why?
| | Bilirubin | 1 | 2018 | 26 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2018 | 215 | 0.040 |
Why?
| | Cell Movement | 1 | 2018 | 71 | 0.040 |
Why?
| | Aged | 1 | 2018 | 378 | 0.040 |
Why?
| | Ovulation | 1 | 2017 | 1 | 0.040 |
Why?
| | HeLa Cells | 1 | 2017 | 17 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2017 | 5 | 0.040 |
Why?
| | Cell Fusion | 1 | 1997 | 1 | 0.040 |
Why?
| | Multigene Family | 1 | 2017 | 8 | 0.040 |
Why?
| | Homeostasis | 1 | 2017 | 8 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 11 | 0.040 |
Why?
| | Choline O-Acetyltransferase | 1 | 2017 | 1 | 0.040 |
Why?
| | Astrocytes | 1 | 2017 | 2 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2017 | 2 | 0.040 |
Why?
| | Axons | 1 | 2017 | 4 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 231 | 0.040 |
Why?
| | Middle Aged | 1 | 2018 | 608 | 0.040 |
Why?
| | Mifepristone | 1 | 2016 | 2 | 0.030 |
Why?
| | Luteinizing Hormone | 1 | 2016 | 5 | 0.030 |
Why?
| | Pregnancy Proteins | 1 | 2016 | 1 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 9 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2015 | 22 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 22 | 0.030 |
Why?
| | Muscles | 1 | 1995 | 2 | 0.030 |
Why?
| | Luminescent Measurements | 1 | 2014 | 1 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2014 | 32 | 0.030 |
Why?
| | Computational Biology | 1 | 2014 | 43 | 0.030 |
Why?
| | Rats, Mutant Strains | 1 | 2014 | 1 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2014 | 2 | 0.030 |
Why?
| | Deoxyribonucleases | 1 | 2014 | 2 | 0.030 |
Why?
| | Protein Engineering | 1 | 2014 | 3 | 0.030 |
Why?
| | Microinjections | 1 | 2014 | 4 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 5 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2014 | 6 | 0.030 |
Why?
| | Blastomeres | 1 | 2012 | 1 | 0.030 |
Why?
| | GATA3 Transcription Factor | 1 | 2012 | 1 | 0.030 |
Why?
| | Blastocyst Inner Cell Mass | 1 | 2012 | 1 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2012 | 11 | 0.030 |
Why?
| | Cattle | 1 | 2012 | 24 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2012 | 24 | 0.030 |
Why?
| | GATA2 Transcription Factor | 1 | 2010 | 1 | 0.020 |
Why?
| | Hematopoiesis | 1 | 2010 | 3 | 0.020 |
Why?
| | Methylation | 1 | 2010 | 11 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2010 | 18 | 0.020 |
Why?
| | Cell Cycle | 1 | 2010 | 18 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2010 | 22 | 0.020 |
Why?
| | Apoptosis | 1 | 2010 | 52 | 0.020 |
Why?
| | Protein Kinase C | 1 | 2008 | 4 | 0.020 |
Why?
| | Polyribosomes | 1 | 2007 | 2 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 9 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 3 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2007 | 5 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 30 | 0.020 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 2003 | 4 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2002 | 7 | 0.010 |
Why?
| | Syndrome | 1 | 2002 | 34 | 0.010 |
Why?
| | Analgesics, Opioid | 1 | 2002 | 42 | 0.010 |
Why?
| | Kidney Transplantation | 1 | 2002 | 115 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 525 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2002 | 622 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1997 | 1 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1997 | 3 | 0.010 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 1995 | 2 | 0.010 |
Why?
| | Histocompatibility Antigens | 1 | 1995 | 2 | 0.010 |
Why?
| | MyoD Protein | 1 | 1995 | 4 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 1995 | 7 | 0.010 |
Why?
| | Extremities | 1 | 1995 | 3 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|